ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Citation: For exemplary work in elucidating and manipulating important biological pathways using novel chemical and biochemical tools.
Current position: professor of chemistry and cancer biology, Scripps Research Institute, Florida
Education: B.S., chemistry, University of Miami; Ph.D., organic chemistry, Stanford University
Kodadek on what he hopes to accomplish in the next decade: “I’ve learned how long it takes to accomplish something really important, so 10 years no longer seems like such a long time. Nonetheless, I hope that we will have a new type of high-throughput screening system that would routinely provide high-affinity and -selectivity synthetic ligands to almost any biomolecule that one wished to target. Then use this system to discover antibody biomarkers that would enable the early diagnosis of many different diseases.”
What his colleagues say:“Tom Kodadek has been a leading figure in the field of chemical biology for more than two decades, and he continues to push the frontiers of this field in exciting new directions through innovative technology development and a firm commitment to rigorous mechanistic understanding of complex biological processes.”—Benjamin Cravatt, Scripps Research Institute, California
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter